首页> 外文期刊>Chemico-biological interactions >Chemoprevention by artesunate in a preclinical model of colorectal cancer involves down regulation of β-catenin, suppression of angiogenesis, cellular proliferation and induction of apoptosis
【24h】

Chemoprevention by artesunate in a preclinical model of colorectal cancer involves down regulation of β-catenin, suppression of angiogenesis, cellular proliferation and induction of apoptosis

机译:在结直肠癌的临床前模型中,艺术化的化学预防涉及调节β-catenin,抑制血管生成,细胞增殖和凋亡的诱导

获取原文
获取原文并翻译 | 示例
           

摘要

Abstract Use of anti-inflammatory drugs is well known to decrease the risk of colorectal cancer, one of the most common causes of cancer related mortality. In view of anti-inflammatory property of artesunate reported in various experimental models, the present study was carried out to evaluate its efficacy in rat model where colon carcinogenesis was induced by 1, 2 dimethylhydrazine (DMH). A time course study revealed that two injections of DMH given at an interval of one week resulted in appearance of multiple plaque lesions and aberrant crypt foci in the colon with a peak effect occurring at the end of 8 weeks. An efficacy study carried out with daily oral administration of artesunate (50 and 150?mg/kg) and aspirin (60?mg/kg) showed a marked reduction in pre-neoplastic changes with a significant decrease in the number of aberrant crypt foci, crypt multiplicity and restoration of histoarchitecture. Both the drugs down regulated β-catenin signaling, reduced the levels of angiogenic markers like VEGF, MMP-9 and inhibited cellular proliferation. The anti-cancer effect of these drugs was concomitant with the pro-apoptotic effect as revealed by increased DNA fragmentation, TUNEL positivity and Bax/Bcl 2 immunoreactivity. This is the first study to evaluate the inhibitory effect of artesunate on pre-neoplastic changes in colon where its chemopreventive effect was found to be comparable to that of aspirin. Our study strengthens the previous findings and shows that it has a preventive and therapeutic potential in the treatment of colon cancer. Graphical abstract Display Omitted Highlights ? Artesunate shows chemopreventive effect in DMH-induced colon cancer in rat. ? It suppresses both gross and microscopic pre-neoplastic changes in rat colon. ? It inhibits carcinogenesis, angiogenesis and cellular proliferation. ? It increases DNA fragmentation and induces apoptosis. ? Its anti-cancer effect is comparable to that of aspirin.
机译:摘要众所周知,使用抗炎药的使用可降低结直肠癌的风险,是癌症相关死亡率的最常见原因之一。鉴于各种实验模型报告的artesunate的抗炎特性,进行了本研究以评估其在大鼠模型中的功效,其中结肠癌致癌诱导1,2二甲基肼(DMH)。时间课程研究表明,在一周间隔内给出的两次DMH注射导致在结肠中的多个斑块病变和异常隐窝灶,在8周结束时发生峰值效应。用日常口服施工(50和150×Mg / kg)和阿司匹林(60×mg / kg)进行的疗效研究表明预瘤预测变化的显着降低,并在异常隐窝焦点的数量下显着降低, crypt yourplipity和histoArchitecture的恢复。药物向下调节β-catenin信号传导,降低了VEGF,MMP-9等血管生成标志物的水平,并抑制细胞增殖。这些药物的抗癌作用伴随着通过增加DNA碎片,Turnel阳性和Bax / Bcl 2免疫反应显示的促凋亡效应。这是第一项评估艺术素对结肠前瘤中瘤中的抑制作用的研究,其中发现其化学预防效应与阿司匹林相当。我们的研究加强了以前的发现,并表明它具有治疗结肠癌的预防性和治疗潜力。图形抽象显示省略了亮点?青蒿琥酯显示大鼠DMH诱导的结肠癌中的化学预防效果。还它抑制了大鼠结肠的总粗糙和显微瘤预瘤变化。还它抑制致癌,血管生成和细胞增殖。还它会增加DNA碎片并诱导细胞凋亡。还其抗癌效应与阿司匹林的抗癌效果相当。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号